An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers. The S-1 Gastrointestinal Cancer Study Group

• SUGIMACHI K

収録刊行物

• Oncology

  Oncology 57 202-210, 1999

詳細情報

• CRID: 1570291225460403584
• NII論文ID: 10018226910
• データソース種別:
  • CiNii Articles